Gene Solutions and AMPATH Unveil Advanced Genomics Lab in Hyderabad

Gene Solutions, a prominent name in genetic testing across Asia, has officially launched an advanced genomics laboratory in Hyderabad in partnership with AMPATH, a leading provider of diagnostic services in India. This new facility, inaugurated on October 1, 2025, aims to enhance access to precision medicine for patients and healthcare providers throughout the country.

Combining the strengths of Gene Solutions and AMPATH, this collaboration leverages next-generation sequencing (NGS) technologies, which are poised to improve testing in critical areas such as reproductive health, cancer screening, and personalized medicine. The new laboratory is expected to play a vital role in making advanced genomic testing more accessible and informative.

Expanding Access to Advanced Diagnostics

With AMPATH’s extensive infrastructure, which includes over 20 satellite laboratories and more than 2,000 collection points across India, the partnership is well-positioned to introduce genomic testing into routine diagnostics. The Hyderabad facility will offer a range of services that support better patient care through advanced testing methodologies.

This collaboration is set to provide timely and informative genomic solutions, equipping healthcare professionals with the tools necessary for more informed clinical decisions. By integrating these innovative technologies into everyday healthcare practices, the partnership seeks to elevate standards in diagnostics and patient outcomes.

A Vision for Inclusive Precision Medicine

“This partnership reflects a shared vision—making high-quality, science-driven genetic testing more widely available,” stated Dr. Nguyen Hoai Nghia, Co-founder and CEO of Gene Solutions. He emphasized the importance of inclusivity in healthcare technology and expressed confidence that working with AMPATH would facilitate the delivery of advanced solutions through a trusted network.

Meanwhile, Dr. Maneesh Bagai, COO of AMPATH, highlighted the excitement surrounding this strategic alliance. “We are thrilled to expand into next-generation sequencing through this collaboration. Together, we are redefining what’s possible in diagnostics—whether in maternal health, early cancer detection, or personalized oncology,” he noted.

About the Organizations

AMPATH, or the American Institute of Pathology and Laboratory Sciences, is recognized for its commitment to quality and adherence to international standards in clinical diagnostics. Headquartered in Hyderabad, the organization operates a Central Reference Laboratory and a growing network of satellite labs, all accredited by the National Accreditation Board for Testing & Calibration Laboratories (NABL).

In addition to its diagnostics services, AMPATH is part of the CTSI South Asia group, which includes the American Oncology Institute (AOI) and a network of specialty hospitals focused on patient-centered healthcare.

Gene Solutions, a multinational biotechnology company, stands at the forefront of genetic testing and research innovation in the Asia-Pacific region. The company utilizes NGS and artificial intelligence to offer a comprehensive portfolio, including non-invasive prenatal testing (NIPT), cancer screening via circulating tumor DNA (ctDNA), genomic profiling, and treatment monitoring. With over two million genetic tests delivered, Gene Solutions is noted for its research contributions and collaborations that advance precision medicine.

For more information, visit: https://genesolutions.com/